Not really. Based on their previous reports I rea
Post# of 148187
(Total Views: 432)
Posted On: 03/09/2020 11:28:56 PM
Not really. Based on their previous reports I read, the $1.50 was based only on combo HIV sales for part of 2020 with a 80% DCF. He follows the company close, but I don't understand the $1.50 price target or why no other indication is included with large DCFs. My guess is it is just a 'cover your ass' type price for an OTC stock.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼